Galectin Therapeutics Inc (NASDAQ:GALT)

3.46
Delayed Data
As of Apr 20
 -0.21 / -5.72%
Today’s Change
1.28
Today|||52-Week Range
6.74
+3.59%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.67
Today’s open3.64
Day’s range3.44 - 3.72
Volume282,313
Average volume (3 months)728,285
Market cap$183.2M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+32.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book55.41

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.10-8.33%
TRILTrillium Therapeutic...-0.15-2.10%
VRMLVermillion Inc+0.08+6.96%
IDXGInterpace Diagnostic...+0.00+0.08%
Data as of 4:00pm ET, 04/20/2018

Financials

Last reporting dateMarch 30, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts